- KR₩290bn
- KR₩286bn
- KR₩138bn
- 73
- 55
- 36
- 58
Annual balance sheet for Boditech Med, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 58,343 | 68,457 | 60,447 | 76,184 | 61,710 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 35,611 | 26,846 | 23,442 | 28,602 | 31,328 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 121,440 | 131,083 | 117,307 | 138,679 | 135,822 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 30,790 | 45,360 | 58,158 | 56,441 | 61,871 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 163,475 | 192,242 | 195,656 | 227,902 | 254,674 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 33,301 | 27,113 | 16,121 | 27,264 | 27,386 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 43,616 | 41,154 | 32,101 | 41,703 | 44,405 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 119,859 | 151,088 | 163,555 | 186,198 | 210,269 |
| Total Liabilities & Shareholders' Equity | 163,475 | 192,242 | 195,656 | 227,902 | 254,674 |
| Total Common Shares Outstanding |